CH643458A5 - Pharmaceutical composition and a process for its production - Google Patents

Pharmaceutical composition and a process for its production Download PDF

Info

Publication number
CH643458A5
CH643458A5 CH541678A CH541678A CH643458A5 CH 643458 A5 CH643458 A5 CH 643458A5 CH 541678 A CH541678 A CH 541678A CH 541678 A CH541678 A CH 541678A CH 643458 A5 CH643458 A5 CH 643458A5
Authority
CH
Switzerland
Prior art keywords
medicament according
pyrazolo
ethyl
phosphodiesterase inhibitor
pharmaceutically acceptable
Prior art date
Application number
CH541678A
Other languages
German (de)
English (en)
Inventor
Pedro Cuatrecasas
Salvador Moncada
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of CH643458A5 publication Critical patent/CH643458A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CH541678A 1977-05-20 1978-05-18 Pharmaceutical composition and a process for its production CH643458A5 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79900777A 1977-05-20 1977-05-20
GB3526177 1977-08-23

Publications (1)

Publication Number Publication Date
CH643458A5 true CH643458A5 (en) 1984-06-15

Family

ID=26262642

Family Applications (1)

Application Number Title Priority Date Filing Date
CH541678A CH643458A5 (en) 1977-05-20 1978-05-18 Pharmaceutical composition and a process for its production

Country Status (8)

Country Link
JP (1) JPS542335A (enrdf_load_stackoverflow)
CH (1) CH643458A5 (enrdf_load_stackoverflow)
DE (1) DE2821737A1 (enrdf_load_stackoverflow)
FR (1) FR2390964A1 (enrdf_load_stackoverflow)
HU (1) HU180548B (enrdf_load_stackoverflow)
IT (1) IT1105506B (enrdf_load_stackoverflow)
NL (1) NL7805402A (enrdf_load_stackoverflow)
SE (1) SE443716B (enrdf_load_stackoverflow)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA787353B (en) * 1978-05-17 1980-08-27 Wellcome Found Pharmaceutical formulations
DE3526362A1 (de) * 1985-07-19 1987-01-22 Schering Ag Prostacycline, ihre analoga oder prostaglandine und thromboxanantagonisten zur behandlung von thrombotischen und thromboembolischen krankheitsbildern
DE3874440T2 (de) * 1987-07-14 1993-01-28 Sankyo Co Zusammensetzung zur herstellung von antithrombotischen medizinischen erzeugnissen.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2235678A1 (en) * 1973-07-02 1975-01-31 Merck & Co Inc Topical antipsoriasis agents - contg. prostaglandin E1 or E2

Also Published As

Publication number Publication date
NL7805402A (nl) 1978-11-22
FR2390964B1 (enrdf_load_stackoverflow) 1980-07-11
IT1105506B (it) 1985-11-04
IT7849485A0 (it) 1978-05-22
SE7805707L (sv) 1978-11-21
SE443716B (sv) 1986-03-10
DE2821737A1 (de) 1978-11-30
FR2390964A1 (fr) 1978-12-15
JPS542335A (en) 1979-01-09
DE2821737C2 (enrdf_load_stackoverflow) 1988-05-19
HU180548B (en) 1983-03-28

Similar Documents

Publication Publication Date Title
DE3490583T1 (de) Analgetische und anti-inflammatorische Mittel und Verfahren zu ihrer Verwendung
DE10325813B4 (de) Prophylaxe und/oder Therapie bei der portalen Hypertonie
DE3390114C2 (enrdf_load_stackoverflow)
DE2520978C3 (de) Dosierungseinheit einer festen, oral zu verabreichenden Arzneiform von wasserlöslichen Xanthin-Derivaten
EP0306846A2 (de) Neue synergistische Kombination bestehend aus einem Phosphodiesterase-Hemmer und einem Thromboxan-A2-Antagonisten und deren Verwendung bzw. Herstellung
US4393063A (en) Treatment for gastric lesions
CH643458A5 (en) Pharmaceutical composition and a process for its production
EP0132595B1 (de) Tokolytisches Mittel
EP0524512B1 (de) Antihypertensive Kombination
DE69903546T2 (de) Levosimendan für die behandlung von pulmonaler hypertonie
DE3904795C2 (de) Pharmazeutisches Präparat und dessen Verwendung
DE69325512T2 (de) Verwendung von remacemid zur behandlung des morbus parkinson
EP0557876B1 (de) Verwendung von Xanthinderivaten zur Behandlung von Muskelschädigungen nach vollständiger Unterbrechung der Blutzirkulation
DE602004005000T2 (de) Methode zur behandlung von niereninsuffizienz
DE3213579C2 (enrdf_load_stackoverflow)
EP0331871A2 (de) Antipsychotisch wirksames Imidazobenzodiazepin
DE3406837C2 (enrdf_load_stackoverflow)
DE1617336C2 (de) Arzneimittel gegen Angina pectoris
DE1941583C3 (de) Analgeticum
DE2030932C3 (de) Arzneimittel zur oralen Behandlung von Oxalatsteinen
DE2055930A1 (de) Verbesserte orale Applikationsform von Raubasin
EP1312365A1 (de) Pteridinone zur Behandlung der erektilen Dysfunktion
EP0260527A2 (de) Neue synergistische Kombination bestehend aus einem Phosphodiesterase-Hemmer und einem Tromboxan-A2-Antagonisten und deren Verwendung bzw. Herstellung
DE3348444C2 (de) Analgetische und antiinflammatorische Mittel
WO1999017756A2 (de) Methode zur verhinderung der transplantatabstossung

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased